Relationship to Dose of Triamcinolone Acetonide and Methylyprednisolone to Improvement in Subacromial Bursitis

Completed · Not applicable

Conditions studied: Subacromial Bursitis, Shoulder Pain

In brief

It is currently unknown whether or not the improvement in pain and function related to a "steroid shot" for shoulder pain due to subacromial bursitis is important. This study seeks to determine whether 20 mg or 40 mg of either triamcinolone or methylprednisolone significantly affect improvement in shoulder pain 6 weeks after injection.

Key facts

Study ID

NCT02242630

Run by

Keesler Air Force Base Medical Center

People needed

61

Starts

2014-09-01

Expected to finish

2016-03-01

Last updated by the study team

2016-12-14

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age 18 years or older
• History and physical examination consistent with shoulder pain and subacromial bursitis
• At least 2 weeks of shoulder pain and subacromial bursitis

You may not qualify if…

• Known allergies to Lidocaine, Marcaine, Methylprednisolone, and/or Triamcinolone
• History or examination suspicious for a humeral head fracture
• History or examination consistent with adhesive capsulitis (normal X-Ray of the shoulder but with less than 100 degrees of active or passive elevation of the arm, when raising the arm above the head to a maximum with passive external rotation being 50 degrees less than the unaffected side
• History or examination consistent with acute synovitis of the glenohumeral or acromioclavicular joint
• Any shoulder surgery involving the affected arm within the last 6 months

Where it is running

• Keesler Medical Center — Keesler Air Force Base, Mississippi, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.